ExLibris header image
SFX Logo
Title: Advancing a clinically relevant perspective of the clonal nature of cancer
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Ruiz, C yr:2011


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Huang, Andrew T. "Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization." BMC cancer 11.1 (2011): 143-143. Link to Full Text for this item Link to SFX for this item
2. Salk, Jesse J. "Passenger mutations as a marker of clonal cell lineages in emerging neoplasia." Seminars in cancer biology 20.5 (2010): 294-303. Link to SFX for this item
3. Hatzis, Christos F. "A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer." JAMA (Chicago, Ill.) 305.18 (2011): 1873-1881. Link to SFX for this item
4. Ross, Stefan S. "TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab." Breast cancer research and treatment 132.3 (2012): 781-91. Link to Full Text for this item Link to SFX for this item
5. Perou, Sara M. "Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer." Breast cancer research and treatment 128.1 (2011): 127-136. Link to Full Text for this item Link to SFX for this item
6. Davis, R. "Methodological and practical challenges for personalized cancer therapies." Nature Reviews Clinical Oncology 8.3 (2011): 135-141. Link to SFX for this item
7. Moore, B. "Global analysis of disease-related DNA sequence variation in 10 healthy individuals: Implications for whole genome-based clinical diagnostics." Genetics in medicine 13.3 (2011): 210-217. Link to Full Text for this item Link to SFX for this item
8. Nei, M. "The Neutral Theory of Molecular Evolution in the Genomic Era." Annual review of genomics and human genetics 11.1 (2010): 265-289. Link to Full Text for this item Link to SFX for this item
9. Itoh, M. "Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers." Breast cancer research and treatment 143.2 (2014): 403-409. Link to Full Text for this item Link to SFX for this item
10. Xue, J. "MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity." Oncogene 35.4 (2015): 448-458. Link to Full Text for this item Link to SFX for this item
11. Wahba, A. "Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC." Medical oncology 29.2 (2012): 454-458. Link to SFX for this item
12. Burke, Harry B. "Genomic Predictor of Survival After Chemotherapy for Breast Cancer." JAMA (Chicago, Ill.) 306.7 (2011): 708-708. Link to SFX for this item
13. Hyung, S. "A Serum Protein Profile Predictive of the Resistance to Neoadjuvant Chemotherapy in Advanced Breast Cancers." Molecular & cellular proteomics 10.10 (2011). Link to Full Text for this item Link to SFX for this item
14. Davies, Eleri L. "Breast cancer." Medicine 40.1 (2012): 5-9. Link to SFX for this item
15. Gilissen, C. "Disease gene identification strategies for exome sequencing." European journal of human genetics 20.5 (2012): 490-497. Link to Full Text for this item Link to SFX for this item
16. Kaklamani, Virginia G. "Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib." Breast cancer research and treatment 132.3 (2011): 833-42. Link to Full Text for this item Link to SFX for this item
17. Huo, Q. "P53-Binding protein 1: A new player for tumorigenesis and a new target for breast cancer treatment." Medical hypotheses 77.3 (2011): 359-363. Link to SFX for this item
18. Tursz, T. "Implications of personalized medicine-perspective from a cancer center." Nature Reviews Clinical Oncology 8.3 (2011): 177-183. Link to SFX for this item
19. Segal, B L. "The pathophysiology of angina pectoris." Geriatrics 37.8 (1982): 74-2. Link to SFX for this item
20. He, X. "One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells." Nanoscale 3.7 (2011): 2936-2942. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced